AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
North America Commercial Headquarters
1800 Concord Pike
P.O. Box 15437
Wilmington, DE 19850
+1 (302) 886-3000
RELATED ARTICLES
Researcher Profile: Roland Kolbeck
Dr. Kolbeck led a team of researchers to develop what has become AstraZeneca’s first respiratory bio…
READ MORE
A New Era for Asthma Treatment
With more than 100 medicines for respiratory diseases currently in development and 49 medicines for…
READ MORE
Researcher Profile: David Cobden
Learn about what America's biopharmaceutical companies are doing to ensure we can continue to afford…
READ MORE
Improving Cancer Treatment by Studying DNA Damage Response
DNA damage response (DDR) is a term used to describe the network of cellular pathways that minimize…
READ MORE
Searching for a Cure for Heart Failure
Researchers at AstraZeneca have focused extensive research and resources on developing a treatment t…
READ MOREPOPULAR ARTICLES
Can We Afford the New Era of Medicine?
Innovative treatments require innovative partnerships. America's Biopharmaceutical Companies and insurers are partnering to get the right medicine in the hands of patients who need them.
READ MORE
Researcher Profile: Victor Sloan
As vice president and development strategy lead at UCB, Victor Sloan has worked in the field of rheumatology since the early 1990's.
READ MORE
We Cannot Take Progress for Granted
We are in a new era of medical discovery and have the potential to revolutionize the treatment of costly and debilitating diseases. But we must not take this progress for granted.
READ MORE
The Greatest Gift of All: Hope
My son Parker's journey with juvenile arthritis (JA) began 10 years ago when he was in elementary school.
READ MORE
Migraine: More than Just a Bad Headache
Migraine is a debilitating neurological disease that is often misunderstood by those who do not suffer symptoms, according to the Migraine Impact Report, a new survey recently released by Eli Lilly and Company and conducted by Nielsen.
READ MORE
The Promise of Personalized Medicine
Discover how America's Biopharmaceutical Companies developed groundbreaking weapons to destroy the body's rogue cells.
READ MORE
Tackling Neurological Disorders in New Ways
Chronic pain. Alzheimer's disease. Multiple Sclerosis. Brain tumors. These are some of the most well-known and prevalent diseases afflicting the more than 100 million Americans who are impacted by a neurological disorder.
READ MORE